April 29 (Reuters) - Verona Pharma PLC I9SAy.F:
VERONA PHARMA Q1 OPERATING EXPENSES USD 86.573 MILLION
VERONA PHARMA Q1 PRETAX PROFIT USD -16.558 MILLION VERSUS. IBES ESTIMATE USD -17.4 MILLION
VERONA PHARMA Q1 OPERATING INCOME USD -10.317 MILLION VERSUS. IBES ESTIMATE USD -13.6 MILLION
VERONA PHARMA Q1 BASIC EPS USD -0.02
VERONA PHARMA Q1 NET INCOME USD -16.319 MILLION VERSUS. IBES ESTIMATE USD -16.1 MILLION
Source text: ID:nGNXbDY9zb
Further company coverage: [I9SAy.F]
((Reuters.Briefs@thomsonreuters.com;))